Is EDHF an epoxyeicosatrienoic acid?

Trends in Pharmacological Sciences

Volumn 21, Issue 4, 2000, Pages 121-124

  Quilley, John ^a   McGiff, John C ^b  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ICOSANOID;

ARACHIDONIC ACID METABOLISM; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

8,11,14-EICOSATRIENOIC ACID; ACETYLCHOLINE; ANIMALS; BIOLOGICAL FACTORS; BRADYKININ; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; GAP JUNCTIONS; HUMANS; VASODILATOR AGENTS;

EID: 0034177115     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01445-0     Document Type: Short Survey

References (34)

1. Fisslthaler B.et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 401:1999;493-497.
2. Hecker M.et al. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. 481:1994;407-414.
3. Campbell W.B.et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78:1996;415-423.
4. Fulton D.et al. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114:1995;99-102.
5. McGiff J.C. Cytochrome P450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31:1991;339-369.
6. Capdevila J.H.et al. Cytochrome P450 and the arachidonate cascade. FASEB J. 6:1992;731-736.
7. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am. J. Physiol. 264:1993;H327-H335.
8. + channel activity. Am. J. Physiol. 270:1996;F822-F832.
9. G-nitro-L-arginine in rats. Am. J. Physiol. 263:1992;H1090-H1094.
10. Hwa J.J.et al. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am. J. Physiol. 266:1994;H952-H958.
11. Shimokawa H.et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol. 28:1996;703-711.
12. Oltman C.L.et al. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary circulation. Circ. Res. 83:1998;932-939.
13. Daikh B.E.et al. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J. Pharmacol. Exp. Ther. 271:1994;1427-1433.
14. Fulton D.et al. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J. Pharmacol. Exp. Ther. 287:1998;497-503.
15. 2+ entry in human and bovine endothelial cells. J. Physiol. 482:1995;259-274.
16. 2+ entry in porcine aortic endothelial cells. Br. J. Pharmacol. 121:1997;1579-1588.
17. + channel on pig coronary artery endothelial cells. J. Physiol. 504:1997;537-543.
18. 2+ in anterior pituitary cells. Biochem. Biophys. Res. Commun. 139:1986;1188-1194.
19. Madhun Z.T.et al. An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells. J. Clin. Invest. 88:1991;456-461.
20. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 396:1998;269-272.
21. Weintraub N.L.et al. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ. Res. 81:1997;258-267.
22. Zygmunt P.M.et al. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118:1996;1147-1152.
23. Mombouli J.-V., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol. Sci. 18:1997;252-256.
24. Bauersachs J.et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
25. Gebremedhin D.et al. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J. Vasc. Res. 35:1998;274-284.
26. Eckman D.M.et al. Endothelium-dependent relaxation and hyperpolarization in guinea pig coronary artery: role of epoxyeicosatrienoic acid. Br. J. Pharmacol. 124:1998;181-189.
27. Rapacon M.et al. Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat. Br. J. Pharmacol. 118:1996;1504-1508.
28. Dong H.et al. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br. J. Pharmacol. 120:1997;695-701.
29. Popp R.et al. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J. Physiol. 497:1996;699-709.
30. Doughty J.M.et al. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am. J. Physiol. 276:1999;H1107-H1112.
31. Kristek F., Gerova M. Myoendothelial relations in the conduit coronary artery of the dog and rabbit. J. Vasc. Res. 29:1992;29-32.
32. Little T.L.et al. Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall. Circ. Res. 76:1995;498-504.
33. Christ G.J.et al. Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ. Res. 79:1996;631-646.
34. 2. Circ. Res. 84:1999;53-63.